Tuberculosis surveillance and monitoring in Europe 2016
The eighth report launched jointly by ECDC and the WHO Regional Office for Europe indicates that, despite notable progress in the past decade, tuberculosis (TB) is still a public health concern in many countries across Europe.
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA – January 2016
This report describes the geographical and temporal distribution of multidrug-resistant tuberculosis based on molecular typing data (24-locus MIRU–VNTR genotyping) as reported by EU/EEA countries.
Tuberculosis surveillance and monitoring in Europe, 2017
This report, the ninth report launched jointly by ECDC and the WHO Regional Office for Europe, presents the latest data on the status of tuberculosis in Europe.
1st Eastern Partnership Ministerial Conference on Tuberculosis and Multi-Drug Resistance Tuberculosis
High-level meeting to discuss the burden of TB and MDR TB and its elimination as a public health problem in the EU/EEA and Eastern Partnership countries.
The burden of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB
This infographic shows the burden in the EU of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB based on data from the 2014 surveillance report
European Union Standards for Tuberculosis Care - 2017 update
ECDC and the European Respiratory Society (ERS) have developed the European Union Standards for Tuberculosis Care (ESTC).
Every hour 30 people are diagnosed with tuberculosis in the European Region. It’s time to make TB a disease of the past
The latest ECDC/WHO report Tuberculosis surveillance and monitoring in Europe 2019 (2017 data) shows that despite an overall decline in numbers of people suffering from TB, the disease remains a major public health challenge in the Region.